Analysts Are Neutral on Top Healthcare Stocks: Bausch Health Companies (BHC), Sanofi (SNYNF)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bausch Health Companies (BHC)
TD Cowen analyst Michael Nedelcovych maintained a Hold rating on Bausch Health Companies yesterday and set a price target of $7.00. The company's shares closed last Friday at $5.71.
According to TipRanks.com, Nedelcovych has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -15.8% and a 27.9% success rate. Nedelcovych covers the Healthcare sector, focusing on stocks such as Takeda Pharmaceutical Company, Molecular Partners AG, and Coherus Biosciences.
Currently, the analyst consensus on Bausch Health Companies is a Hold with an average price target of $8.33, implying a 44.1% upside from current levels. In a report issued on July 25, Truist Financial also maintained a Hold rating on the stock with a $6.78 price target.
Sanofi (SNYNF)
Kepler Capital analyst Nicolas Pauillac maintained a Hold rating on Sanofi on July 31 and set a price target of EUR95.00. The company's shares closed last Friday at $92.56, close to its 52-week low of $88.90.
According to TipRanks.com, Pauillac is ranked #974 out of 9914 analysts.
Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $127.69, implying a 38.0% upside from current levels. In a report issued on July 17, Deutsche Bank also maintained a Hold rating on the stock with a EUR100.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
a day ago
- Business Insider
Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bausch + Lomb Corporation (BLCO – Research Report), Resmed (RMD – Research Report) and Envista Holdings (NVST – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch + Lomb Corporation (BLCO) J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Bausch + Lomb Corporation on July 30 and set a price target of $13.00. The company's shares closed last Friday at $13.50, close to its 52-week low of $13.16. According to Marcus is a 4-star analyst with an average return of 8.8% and a 52.8% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Merit Medical Systems. Bausch + Lomb Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $14.69, implying an 8.2% upside from current levels. In a report issued on July 30, Needham also maintained a Hold rating on the stock. Resmed (RMD) J.P. Morgan analyst David Low maintained a Buy rating on Resmed yesterday and set a price target of $310.00. The company's shares closed last Friday at $279.20. According to Low is a 4-star analyst with an average return of 7.6% and a 57.0% success rate. Low covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Cochlear, and CSL. Resmed has an analyst consensus of Strong Buy, with a price target consensus of $295.40, implying a 4.8% upside from current levels. In a report released yesterday, KeyBanc also maintained a Buy rating on the stock with a $298.00 price target. Envista Holdings (NVST) J.P. Morgan analyst Rachel Vatnsdal maintained a Hold rating on Envista Holdings yesterday and set a price target of $20.00. The company's shares closed last Friday at $20.83. According to Vatnsdal is a 1-star analyst with an average return of -1.2% and a 39.3% success rate. Vatnsdal covers the Healthcare sector, focusing on stocks such as Caris Life Sciences, Inc., Twist Bioscience, and Myriad Genetics. Envista Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $22.17, which is a 9.6% upside from current levels. In a report issued on July 29, UBS also maintained a Hold rating on the stock with a $22.00 price target.
Business Insider
a day ago
- Business Insider
Analysts' Opinions Are Mixed on These Financial Stocks: Lendingtree (TREE), Flagstar Financial (FLG) and Houlihan Lokey (HLI)
Analysts have been eager to weigh in on the Financial sector with new ratings on Lendingtree (TREE – Research Report), Flagstar Financial (FLG – Research Report) and Houlihan Lokey (HLI – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lendingtree (TREE) J.P. Morgan analyst Melissa Wedel maintained a Buy rating on Lendingtree yesterday and set a price target of $66.00. The company's shares closed last Friday at $49.47. According to Wedel is a 4-star analyst with an average return of 10.5% and a 67.1% success rate. Wedel covers the Financial sector, focusing on stocks such as MidCap Financial Investment Corporation, Blackstone Secured Lending Fund, and Sixth Street Specialty Lending. Lendingtree has an analyst consensus of Strong Buy, with a price target consensus of $66.40, implying a 37.3% upside from current levels. In a report issued on July 24, KBW also maintained a Buy rating on the stock with a $66.00 price target. Flagstar Financial (FLG) J.P. Morgan analyst Anthony Elian maintained a Hold rating on Flagstar Financial on July 31 and set a price target of $12.50. The company's shares closed last Friday at $11.20. According to Elian has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.7% and a 32.0% success rate. Elian covers the Financial sector, focusing on stocks such as Zions Bancorporation National Association, Pinnacle Financial Partners, and First Citizens BancShares. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Flagstar Financial with a $13.45 average price target, representing a 19.6% upside. In a report issued on July 28, TR | OpenAI – 4o also initiated coverage with a Hold rating on the stock with a $11.50 price target. Houlihan Lokey (HLI) J.P. Morgan analyst Ken Worthington maintained a Hold rating on Houlihan Lokey on July 30 and set a price target of $197.00. The company's shares closed last Friday at $189.79, close to its 52-week high of $192.10. According to Worthington is a 4-star analyst with an average return of 2.9% and a 52.9% success rate. Worthington covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Apollo Global Management, and Victory Capital Holdings. Houlihan Lokey has an analyst consensus of Moderate Buy, with a price target consensus of $197.17.
Business Insider
a day ago
- Business Insider
Analysts Offer Insights on Materials Companies: Dow Inc (DOW) and Anglo American (OtherAAUKF)
Analysts have been eager to weigh in on the Materials sector with new ratings on Dow Inc (DOW – Research Report) and Anglo American (AAUKF – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Dow Inc (DOW) In a report released today, John McNulty from BMO Capital maintained a Sell rating on Dow Inc, with a price target of $20.00. The company's shares closed last Friday at $25.51. According to McNulty is a 3-star analyst with an average return of 2.0% and a 52.6% success rate. McNulty covers the Basic Materials sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and Axalta Coating Systems. Dow Inc has an analyst consensus of Hold, with a price target consensus of $28.14. Anglo American (AAUKF) In a report released today, Liam Fitzpatrick from Deutsche Bank reiterated a Buy rating on Anglo American, with a price target of p2600.00. The company's shares closed last Friday at $31.68. Fitzpatrick has an average return of 5.1% when recommending Anglo American. According to Fitzpatrick is ranked #1913 out of 9927 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Anglo American with a $31.73 average price target, representing a 6.0% upside. In a report issued on July 25, Barclays also maintained a Buy rating on the stock with a £27.20 price target.
